Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03374839
Title Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients (Nivo-TIL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nantes University Hospital
Indications

melanoma

Therapies

Aldesleukin + Nivolumab + tumor infiltrating lymphocytes

Age Groups: adult | senior
Covered Countries


No variant requirements are available.